Literature DB >> 21144246

Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis.

F M R Perrin1, N Woodward, P P J Phillips, T D McHugh, A J Nunn, M C I Lipman, S H Gillespie.   

Abstract

SETTING: Royal Free Hospital, London.
OBJECTIVE: To investigate the relationship between sputum mycobacterial load, assessed by time to positivity (TTP) in liquid culture, radiological cavitation and change in sputum bacterial load in response to anti-tuberculosis treatment.
DESIGN: The study was conducted on 95 patients treated for sputum culture-positive pulmonary tuberculosis (TB), with pre-treatment TTP and baseline chest X-ray (CXR). Of these, 31 had chest computed tomography scans assessed for number and volume of cavities. The microbiological treatment response was measured in 56 patients with serial TTP, and related to baseline radiological cavitation.
RESULTS: Cavitation was present in 48% of patients, and was associated with a shorter TTP at baseline (P < 0.001). Patients with more cavities and greater total cavitary volume had a shorter TTP (P < 0.001 for both). No difference was demonstrated in the rate of change in TTP on treatment (P = 0.36) between patients with and without cavities.
CONCLUSION: This study confirms that cavitation is associated with higher baseline sputum mycobacterial load. The rate of decline in bacterial load in response to treatment is similar in patients with and without radiologically demonstrable cavities, suggesting that response to, and hence duration of, effective treatment may be predicted by the initial number of organisms present in the sputum.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144246

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  36 in total

1.  A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Pamela Nabeta; Amy L Davidow; Viral Vadwai; Rasim Tahirli; Vanisha Munsamy; Mark Nicol; Martin Jones; David H Persing; Doris Hillemann; Sabine Ruesch-Gerdes; Felicity Leisegang; Carlos Zamudio; Camilla Rodrigues; Catharina C Boehme; Mark D Perkins; David Alland
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

Review 2.  Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.

Authors:  Anca Dorhoi; Stefan H E Kaufmann
Journal:  Semin Immunopathol       Date:  2015-10-05       Impact factor: 9.623

3.  Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand.

Authors:  Sakarn Charoensakulchai; Manasak Limsakul; Inkharat Saengungsumalee; Sirawich Usawachoke; Aticha Udomdech; Anintita Pongsaboripat; Wisit Kaewput; Boonsub Sakboonyarat; Ram Rangsin; Picha Suwannahitatorn; Mathirut Mungthin; Phunlerd Piyaraj
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

4.  Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression.

Authors:  Colleen F Hanrahan; Grant Theron; Jean Bassett; Keertan Dheda; Lesley Scott; Wendy Stevens; Ian Sanne; Annelies Van Rie
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

5.  Diverse Cavity Types and Evidence that Mechanical Action on the Necrotic Granuloma Drives Tuberculous Cavitation.

Authors:  Elizabeth A Ihms; Michael E Urbanowski; William R Bishai
Journal:  Am J Pathol       Date:  2018-05-23       Impact factor: 4.307

6.  Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.

Authors:  Matheus de Matto Pires; Giovana Rodrigues Pereira; Márcia Silva Barbosa; Natan José Dutra Dias; Carina Secchi; Jociane Saldanha Hoff; Denise Rossato Silva
Journal:  Lung       Date:  2020-10-31       Impact factor: 2.584

7.  Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid.

Authors:  Grant Theron; Jonny Peter; Richard Meldau; Hoosain Khalfey; Phindile Gina; Brian Matinyena; Laura Lenders; Gregory Calligaro; Brian Allwood; Gregory Symons; Ureshnie Govender; Mashiko Setshedi; Keertan Dheda
Journal:  Thorax       Date:  2013-06-29       Impact factor: 9.139

Review 8.  Assessment of treatment response in tuberculosis.

Authors:  Neesha Rockwood; Elsa du Bruyn; Thomas Morris; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2016-03-31       Impact factor: 3.772

9.  A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.

Authors:  Emmanuel Chigutsa; Kashyap Patel; Paolo Denti; Marianne Visser; Gary Maartens; Carl M J Kirkpatrick; Helen McIlleron; Mats O Karlsson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

10.  Caspase-Based PET for Evaluating Pro-Apoptotic Treatments in a Tuberculosis Mouse Model.

Authors:  Alvaro A Ordonez; Sudhanshu Abhishek; Alok K Singh; Mariah H Klunk; Babak Benham Azad; Eric O Aboagye; Laurence Carroll; Sanjay K Jain
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.